Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
PHASE2CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
November 30, 2002
Conditions
Oesophageal Carcinoma
Interventions
DRUG
Epirubicin, Cisplatin, Capecitabine
PROCEDURE
Surgical Resection
Trial Locations (1)
SM2 5PT
Royal Marsden Hospital, Sutton
All Listed Sponsors
lead
Royal Marsden NHS Foundation Trust
OTHER
NCT00220129 - Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus | Biotech Hunter | Biotech Hunter